Stephens & Co. Maintains Overweight on HCA Healthcare, Lowers Price Target to $280
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel maintains an Overweight rating on HCA Healthcare (NYSE:HCA) but has lowered the price target from $300 to $280.
October 25, 2023 | 3:42 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HCA Healthcare's price target has been lowered from $300 to $280 by Stephens & Co., though the Overweight rating is maintained.
The lowering of the price target by Stephens & Co. could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained Overweight rating indicates that the analyst still sees the stock as a good investment, which could counterbalance the negative impact of the lowered price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100